A Randomized, Placebo Controlled, Double-Blind Phase II Study to Evaluate Safety, Immunogencitiy and Prevention of Infection with Mycobacterium tuberculosis (Mtb) of H56:IC31 in Healthy Adolescents

Trial Profile

A Randomized, Placebo Controlled, Double-Blind Phase II Study to Evaluate Safety, Immunogencitiy and Prevention of Infection with Mycobacterium tuberculosis (Mtb) of H56:IC31 in Healthy Adolescents

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Sep 2017

At a glance

  • Drugs H1IC (Primary)
  • Indications Tuberculosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms A-043
  • Sponsors Aeras
  • Most Recent Events

    • 04 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top